Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
PBPH
56
HOLDINGS
14%
ALSO IN OZEM
OZEM
21
HOLDINGS
33%
ALSO IN PBPH
SECTOR DRIFT (PBPH minus OZEM)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBPH |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 15.5% | 13.6% | 13.6% |
|
AMGEN INC | 4.3% | 4.5% | 4.3% |
 |
ASTRAZENECA PLC | 4.7% | 4.0% | 4.0% |
|
PFIZER INC | 3.5% | 8.0% | 3.5% |
|
GILEAD SCIENCES INC | 4.0% | 2.0% | 2.0% |
PBPH Overweight Relative to OZEM
|
JOHNSON & JOHNSON | 10.0% |
|
ABBVIE INC | 7.2% |
|
MERCK & CO. INC. | 5.7% |
 |
NOVARTIS AG | 4.2% |
|
VERTEX PHARMACEUTICALS INC | 2.8% |
|
BRISTOL-MYERS SQUIBB CO | 2.7% |
 |
NOVO NORDISK A/S-B | 2.6% |
|
GILEAD SCIENCES INC | 2.0% |
|
GSK PLC | 2.0% |
 |
SANOFI-AVENTIS | 1.9% |
PBPH Underweight Relative to OZEM
|
NOVO-NORDISK A/S-SPONS ADR | -11.9% |
 |
CHINA PHARMACEUTICAL GROUP | -6.2% |
 |
ASCLETIS PHARMA, INC. | -5.5% |
|
KAILERA THERAPEUTICS INC | -5.5% |
|
VIKING THERAPEUTICS, INC. | -5.0% |
|
PFIZER INC | -4.6% |
 |
HANMI PHARM CO LTD | -4.3% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.1% |
|
ZEALAND PHARMA A/S | -3.7% |
|
JIANGSU HENGRUI PHARMACEUT-H | -2.9% |